LONDON, April 7 – RIA Novosti, Maria Tabak. The British-Swedish company AstraZeneca is working to establish the causes of blood clots after vaccination against coronavirus with its drug, but emphasizes that these are very rare cases.
Earlier, the British Medicines Agency recommended that people under 30 years of age not be vaccinated with AstraZeneca if possible due to rare cases of blood clots. Also on Wednesday, the European Medicines Agency (EMA) said it admits that the AstraZeneca vaccine could be linked to blood clots, which is rare but should be listed as a rare side effect of the drug.
“AstraZeneca is actively working with regulators to amend the description of the drug and is already working to understand the existing cases, epidemiology and possible mechanisms that explain these extremely rare cases,” the company said in a statement to RIA Novosti.